NCT02205840已完成2 期
A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 240
- 主要终点
- Corneal staining score
研究概览
简要总结
The purpose of this study is to assess the safety and effectiveness of SI-614 solution compared with placebo solution in treating patients with dry eye.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be at least 18 years of age
- •Have provided written informed consent
- •Have dry eye in both eyes
排除标准
- •Use of contact lenses
- •Have an uncontrolled systemic disease
- •Have an uncontrolled psychiatric condition, or substance or alcohol abuse
- •Women who is pregnant, nursing or planning a pregnancy
研究组 & 干预措施
Placebo Vehicle
Placebo Comparator
干预措施: Vehicle (Drug)
SI-614
Experimental
干预措施: SI-614 (Drug)
结局指标
主要结局
Corneal staining score
时间窗: Up to 28 days
Symptom score
时间窗: Up to 28 days
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry EyeDry Eye SyndromesNCT01558999Seikagaku Corporation150
已完成
3 期
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry EyeDry Eye DiseaseNCT05411367Seikagaku Corporation232
已完成
3 期
Safety and Efficacy of Travoprost/Timolol BAC-freeOcular HypertensionOpen-Angle GlaucomaNCT00760539Alcon Research87
已完成
3 期
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00672997Alcon Research301
已完成
2 期
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin TherapyType 2 Diabetes MellitusNCT01240759Shionogi218